Vending Machine Naloxone Distribution for Your Community (VENDY): Increasing Reach and Implementation of Naloxone Distribution
Trial Snapshot
- Phase
- Phase 4
- Status
- Active, not recruiting
- Enrollment
- 4,000
- Locations
- 6
- Primary Endpoint
- Reach
Study Overview
Brief Summary
Vending machines are an innovative strategy shown to increase access to naloxone, a medication used to reverse opioid overdose. The aim of this proposal is to study the reach of a community-initiated, stakeholder engaged adaptation of naloxone distribution, VEnding machine Naloxone Distribution for Your community (VENDY) program.
Detailed Description
This pilot assessment of the VENDY program will take place in 3 communities. Each community will have a machine (vending or kiosks) in which naloxone will be distributed for free to community members. Our preliminary work identified the locations desired by community members who use illegal drugs for machine placement. The pilot test test will include evaluation of the reach (naloxone distribution), adoption (% of sites and staff implementing), and implementation (fidelity to restocking and maintenance protocol) of VENDY in each community.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Health Services Research
- Masking
- None
Masking Description
There will be no masking.
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Any person in the community who desires to obtain naloxone will be able to use the machines
Exclusion Criteria
- •Inability to enter a code on a vending machine or open a kiosk.
Arms & Interventions
VENDY
Each participating site will install at least 1 machine (vending or kiosks) in the respective community for naloxone distribution.
Intervention: VENDY (Behavioral)
Outcomes
Primary Outcomes
Reach
Time Frame: the 6 months pre VENDY implementation and the 6 months post VENDY implementation
Reach will be assessed using monthly counts of naloxone distribution in the 6 months before and after VENDY implementation. Naloxone counts will include distribution from all sources within the organization and captured through pharmacy fills from the electronic health record and distribution tracking logs. Naloxone machine distribution will be added to the total monthly count in the post implementation phase and obtained using the vending machine electronic software (reporting date and time of distribution) or (for kiosks) the staff monthly refill tracking log capturing quantity of naloxone kits required to fill the machine (captured at least monthly).
Secondary Outcomes
- Adoption(At the end of program development (program development is the first phase in which each site is developing VENDY over a 6-18 month period of time))
- Fatal Opioid Overdose Events-Effectiveness(pre-implementation in the year prior to a live VENDY program and post implementation in the year following live VENDY program)
- Fidelity-Implementation(the 6 months following VENDY implementation)
- Maintenance(the 6 months following the initial implementation phase (6 months))